171 related articles for article (PubMed ID: 1688733)
21. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
Ekert H
Cancer Treat Res; 1989; 41():241-6. PubMed ID: 2484293
[No Abstract] [Full Text] [Related]
22. An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
Klimo P; Connors JM
Semin Hematol; 1988 Apr; 25(2 Suppl 2):34-40. PubMed ID: 2456621
[TBL] [Abstract][Full Text] [Related]
23. [Cured from Hodgkin's disease].
Brice P
Bull Cancer; 2002; 89(7-8):666-70. PubMed ID: 12206979
[TBL] [Abstract][Full Text] [Related]
24. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Valagussa P; Bonadonna G
Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
[No Abstract] [Full Text] [Related]
26. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
27. Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
Sagher D; Karrison T; Schwartz JL; Larson R; Meier P; Strauss B
Cancer Res; 1988 Jun; 48(11):3084-9. PubMed ID: 2452685
[TBL] [Abstract][Full Text] [Related]
28. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
[TBL] [Abstract][Full Text] [Related]
29. CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease.
Brusamolino E; Castelli G; Pagnucco G; Orlandi E; Malagó D; Lazzarino M; Bernasconi C
Haematologica; 1990; 75(4):340-5. PubMed ID: 1703510
[TBL] [Abstract][Full Text] [Related]
30. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
31. Current approaches to the treatment of advanced-stage Hodgkin's disease.
Rusthoven JJ
CMAJ; 1986 Sep; 135(5):465-73. PubMed ID: 2427176
[TBL] [Abstract][Full Text] [Related]
32. [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
Robert M; Averous M; Lavabre-Bertrand T; Iborra F; Chevallier P; Rebillard X; Guiter J; Grasset D
J Urol (Paris); 1992; 98(3):178-80. PubMed ID: 1282922
[TBL] [Abstract][Full Text] [Related]
33. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
Bonadonna G; Santoro A; Bonfante V; Valagussa P
Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
[TBL] [Abstract][Full Text] [Related]
34. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
35. The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Brown T; Dawson AA; Bennett B; Moore NR
Cancer Genet Cytogenet; 1988 Nov; 36(1):89-102. PubMed ID: 3203299
[TBL] [Abstract][Full Text] [Related]
36. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
37. Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
Bujan L; Walschaerts M; Brugnon F; Daudin M; Berthaut I; Auger J; Saias J; Szerman E; Moinard N; Rives N; Hennebicq S
Fertil Steril; 2014 Sep; 102(3):667-674.e3. PubMed ID: 25044088
[TBL] [Abstract][Full Text] [Related]
38. Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease.
Smith MR; Khanuja PS; al-Katib A; Bishop CR; Andersen J; Hussein ME; Karanes C
Cancer; 1994 Feb; 73(4):1264-9. PubMed ID: 7508818
[TBL] [Abstract][Full Text] [Related]
39. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
Durant JR; Bartolucci A; Gams RA; Dorfman RF; Velez-Garcia E
Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700
[TBL] [Abstract][Full Text] [Related]
40. Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
Rodgers RW; Gamble JF; Loh KK; Shullenberger CC
Cancer; 1980 Dec; 46(11):2349-55. PubMed ID: 6159961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
